24小时热门版块排行榜

返回列表

【奖励】本帖被评价7次，作者soochow增加金币 6.5 个

当前主题已经存档。

当前只显示满足指定条件的回帖，点击这里查看本话题的所有回帖

soochow

木虫 (正式写手)

应助: 0 (幼儿园)
金币: 4256.6
帖子: 572
在线: 162.7小时
虫号: 233402

[资源] 【资源】聚合物治疗【 Advanced Drug Delivery Reviews专辑】

Advanced Drug Delivery Reviews 上最新一期关于聚合物用于治疗的专辑，希望感兴趣的朋友喜欢。
Volume 61, Issue 13,  Pages 1117-1232 (12 November 2009)
Polymer Therapeutics: Clinical Applications and Challenges for Development
Edited by M.J. Vicent and R. Duncan
http://www.sciencedirect.com/sci ... 9-999389986-1536091

附上一篇全文下载
Functional polymers as therapeutic agents: Concept to market place

http://www.namipan.com/d/ADDR%202009-61-1121%20Functional%20polymers%20as%20therapeutic%20agents-Concept%20to%20market%20place.pdf/20e03168e4a6ecc1adcdbd5364e68749375a0dfceee00600

Preface

2. Polymer therapeutics: Clinical applications and challenges for development  Pages 1117-1120  María J. Vicent, Helmut Ringsdorf, Ruth Duncan

  Biologically Active Polymers
3. Functional polymers as therapeutic agents: Concept to market place
Pages 1121-1130  Pradeep K. Dhal, Steven C. Polomoscanik, Louis Z. Avila, S. Randall Holmes-Farley, Robert J. Miller

  Polymer Anticancer Conjugates
4. Development of HPMA copolymer–anticancer conjugates: Clinical experience and lessons learnt  Pages 1131-1148  Ruth Duncan

5. Clinical experience with anthracycline antibiotics–HPMA copolymer–human immunoglobulin conjugates  Pages 1149-1158 nBlanka Rihova

6. Design and development of polymer conjugates as anti-angiogenic agents  Pages 1159-1176  Ehud Segal, Ronit Satchi-Fainaro

7. PEG conjugates in clinical development or use as anticancer agents: An overview  Pages 1177-1188  Gianfranco Pasut, Francesco M. Veronese

8. Design and development of IT-101, a cyclodextrin-containing polymer conjugate of camptothecin
Pages 1189-1192
Mark E. Davis

9. XMT-1001, a novel polymeric camptothecin pro-drug in clinical development for patients with advanced cancer  Pages 1193-1202  Alexander V. Yurkovetskiy, Robert J. Fram

10. Combination therapy: Opportunities and challenges for polymer–drug conjugates as anticancer nanomedicines  Pages 1203-1213  Francesca Greco, María J. Vicent

11. ProLindac™ (AP5346): A review of the development of an HPMA DACH platinum Polymer Therapeutic  Pages 1214-1219  David P Nowotnik, Esteban Cvitkovic

  Key Issues for Transfer from Lab to Clinic
12. Polymeric carriers: Preclinical safety and the regulatory implications for design and development of polymer therapeutics  Pages 1220-1231  Rogério Gaspar, Ruth Duncan

回复此楼